Natera Inc (NTRA)
92.58
+1.30
(+1.42%)
USD |
NASDAQ |
Apr 26, 12:18
Natera Cash from Operations (Quarterly): -58.12M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -58.12M |
September 30, 2023 | -29.56M |
June 30, 2023 | -78.38M |
March 31, 2023 | -80.89M |
December 31, 2022 | -81.13M |
September 30, 2022 | -102.25M |
June 30, 2022 | -110.85M |
March 31, 2022 | -137.28M |
December 31, 2021 | -98.74M |
September 30, 2021 | -91.06M |
June 30, 2021 | -70.56M |
March 31, 2021 | -74.88M |
December 31, 2020 | -73.30M |
September 30, 2020 | -33.13M |
June 30, 2020 | -40.98M |
March 31, 2020 | -35.10M |
December 31, 2019 | -15.05M |
September 30, 2019 | -12.64M |
June 30, 2019 | -3.932M |
March 31, 2019 | -31.82M |
Date | Value |
---|---|
December 31, 2018 | -12.81M |
September 30, 2018 | -23.27M |
June 30, 2018 | -35.54M |
March 31, 2018 | 1.046M |
December 31, 2017 | -28.13M |
September 30, 2017 | -31.30M |
June 30, 2017 | -13.77M |
March 31, 2017 | -24.62M |
December 31, 2016 | -29.65M |
September 30, 2016 | -24.22M |
June 30, 2016 | -20.66M |
March 31, 2016 | 0.471M |
December 31, 2015 | -4.689M |
September 30, 2015 | -17.28M |
June 30, 2015 | -13.37M |
March 31, 2015 | -2.491M |
December 31, 2014 | 10.13M |
September 30, 2014 | 5.843M |
June 30, 2014 | -0.442M |
March 31, 2014 | -5.039M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-137.28M
Minimum
Mar 2022
-3.932M
Maximum
Jun 2019
-64.62M
Average
-73.30M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
Exact Sciences Corp | 69.55M |
Mettler-Toledo International Inc | 281.50M |
Invitae Corp | -66.90M |
Illumina Inc | 224.00M |
Castle Biosciences Inc | 18.59M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 24.66M |
Cash from Financing (Quarterly) | 6.845M |
Free Cash Flow | -286.15M |
Free Cash Flow Per Share (Quarterly) | -0.5671 |
Free Cash Flow to Equity (Quarterly) | -67.95M |
Free Cash Flow to Firm (Quarterly) | -67.66M |
Free Cash Flow Yield | -2.69% |